Palace Hotel
San Francisco, CA
At Wilson Sonsini, we take a tremendous amount of pride in our broad range of industry conferences and programs, which are widely regarded as providing crucial, high-value opportunities for networking, business development, and knowledge-sharing. At the same time, our top priority is the health and safety of everyone involved in our events. As a result, in light of the current COVID-19 pandemic, we have made the difficult decision to cancel the 28th Annual Medical Device Conference, previously scheduled to take place in San Francisco on June 18-19, 2020.
The firm is currently evaluating the possibility of holding a scaled-back, virtual version of this year’s conference at a later date. This page will be updated with any new developments.
The cancellation of this year’s in-person event is not the outcome we had hoped for, but given our overall concern for your well-being, the current uncertainty around the end date for shelter-in-place orders, and our commitment to contributing to global, national, and local efforts to slow the spread of the virus, we believe this is the right decision.
Wilson Sonsini will continue to prioritize your health, safety, and well-being when planning and producing events. We will maintain ongoing communications, so if changes are made to an upcoming program due to COVID-19-related developments, you will be notified as soon as possible. Please visit the Events page on wsgr.com for the latest information on our programs, as well as details regarding our on-demand offerings.
The firm is committed to providing the best possible client service during these unique and challenging times. To help ensure that our clients have ongoing and easy access to our latest updates, we have created the COVID-19 Client Advisory Resource, a single point of collection for alerts, advisories, and programs to help clients maintain key operational and business functions throughout the COVID-19 outbreak. To sign up to receive COVID-19-related communications, please visit the Subscription Center.
Thank you for your understanding.
Norilyn Ingram
ningram@wsgr.comCasey represented innovative companies in the medical devices industry.
Elton specializes in public and private corporate finance and corporate law and governance. He also has considerable M&A and venture capital experience.
Philip focuses primarily on the representation of medical device, biotechnology, pharmaceutical, diagnostic, and digital health companies in corporate governance, IPO, M&A, public company reporting, and private equity and debt financing matters.
Scott advises clients in a broad range of corporate transactions and related matters.
James advises life sciences and tech companies on a wide variety of matters and has extensive experience working with venture capital firms and other investors in private equity and debt financings.
James is a veteran attorney focused on helping medical device companies protect and enforce their domestic and international intellectual property rights.
David represents pharmaceutical, biotechnology, medical device, diagnostic, and dietary supplement clients in the life sciences and healthcare industries.
Farah focuses on the representation of pharmaceutical, biotechnology, medical device, and diagnostic companies in complex collaboration and partnering transactions.
Marty represents innovative life sciences and technology clients in corporate transactions and governance matters.